Risk of breast cancer with progestins in combination with estrogen as hormone replacement therapy
Santen, R.J.; Pinkerton, J.; McCartney, C.; Petroni, G.R.
Journal of Clinical Endocrinology and Metabolism 86(1): 16-23
2001
ISSN/ISBN: 0021-972X PMID: 11231971 DOI: 10.1210/jcem.86.1.7269Document Number: 259732
Document emailed within 0-6 h
Related Documents
2002: New SBU-report on estrogen replacement therapy in climacteric. Moderate risk of breast cancer after long-term use Lakartidningen 99(28-29): 3031-3034Magnusson, C.; Weiderpass, E. 2001: Hormone therapy in climacteric. Different effects of estrogen and gestagen on the risk of breast and endometrial cancer Lakartidningen 98(5): 418-421
Ratanawichitrasin, A.; Reansuwan, W.; Ratanawichitrasin, S.; Bhodhisuwan, K.; Kongpatanakul, S. 2002: Risk of breast cancer in post-menopausal women using hormone replacement therapy Journal of the Medical Association of Thailand 85(5): 583-589
Glaser, A.N. 2000: Estrogen-progestin replacement and risk of breast cancer JAMA 284(6): 692; Author Reply 693-4
Zahl, P-Henrik.; Maehlen, J. 2005: Estrogen replacement therapy and breast cancer Tidsskrift for den Norske Laegeforening: Tidsskrift for Praktisk Medicin Ny Raekke 125(8): 1045; Author Reply 1045
Brewster, W.R.; DiSaia, P.J.; Grosen, E.A.; McGonigle, K.F.; Kuykendall, J.L.; Creasman, W.T. 1999: An experience with estrogen replacement therapy in breast cancer survivors International Journal of Fertility and Women's Medicine 44(4): 186-192
Dryzhak, V.I. 1989: Estrogen antagonists and inhibitors in hormone therapy of breast cancer Voprosy Onkologii 35(7): 771-778
Joseph, K.S. 1995: Breast cancer and hormone-replacement therapy New England Journal of Medicine 333(20): 1356; Author Reply 1357-1358
Spicer, D.; Pike, M.C.; Henderson, B.E. 1990: The question of estrogen replacement therapy in patients with a prior diagnosis of breast cancer Oncology 4(12): 49-54 59; Discussion 59 62
Persson, I. 1996: Cancer risk in women receiving estrogen-progestin replacement therapy Maturitas 23(Suppl): S37-S45
Nachtigall, M.J.; Smilen, S.W.; Nachtigall, R.D.; Nachtigall, R.H.; Nachtigall, L.E. 1992: Incidence of breast cancer in a 22-year study of women receiving estrogen-progestin replacement therapy Obstetrics and Gynecology 80(5): 827-830
Fentiman, I.S. 2002: 20. Oral contraceptives, hormone replacement therapy and breast cancer International Journal of Clinical Practice 56(10): 755-759
Cobleigh, M.A.; Norlock, F.E.; Oleske, D.M.; Starr, A. 1999: Hormone replacement therapy and high S phase in breast cancer JAMA 281(16): 1528-1530
Snyder, G.M.; Sielsch, E.C.; Reville, B. 1998: The controversy of hormone-replacement therapy in breast cancer survivors Oncology Nursing Forum 25(4): 699-706; Quiz: 707-708
Labriola, D.; Pratt, K.; Bufi, P. 2009: 'Natural' hormone replacement and breast cancer risk: evidence for safety and efficacy Oncology 23(7): 639-641
Matsushita, H.; Wakatsuki, A. 2012: Hormone replacement therapy and cancer risk Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 4): 805-809
Li, L.; Ji, J.; Wang, J.-B.; Niyazi, M.; Qiao, Y.-L.; Boffetta, P. 2012: Attributable causes of breast cancer and ovarian cancer in china: reproductive factors, oral contraceptives and hormone replacement therapy Chinese Journal of Cancer Research 24(1): 9-17
Predná, L.; Habánová, M.; Sláviková, E.; Wyka, J. 2015: Hormonal contraceptives and hormone replacement therapy as a possible factor of breast cancer Roczniki Panstwowego Zakladu Higieny 66(3): 269-274
Tavani, A.; La Vecchia, C.; Brinton, L.A.; McTiernan, A. 2001: Hormone replacement therapy and risk of endometrial cancer Tumori 87(5): S20-S21
Grant, E.C.G. 2017: Lifetime cancer risk with progestin and estrogen oral contraceptives and hormone therapy American Journal of Obstetrics and Gynecology 217(2): 232-233